Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » FDA Clears Quidel's Solana MDx Platform, Group A Strep Assay

FDA Clears Quidel's Solana MDx Platform, Group A Strep Assay

Jun 23, 2015
|
staff reporter

NEW YORK (GenomeWeb) – Quidel said today that the US Food and Drug Administration cleared the firm's Solana molecular platform and associated Group A Streptococcus assay. 

Solana leverages the helicase-dependent amplification technology that also underpins Quidel's AmpliVue molecular technology. Solana can process up to 12 patient samples in a 30-minute run, saving time for healthcare professionals in moderately complex settings, Quidel said. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

California Strain

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

Boosting Viral Surveillance

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

Nucleic Acids Research Studies on Pan-Cancer MiRNA Biogenesis Mutations, Skeletal Methylation, More

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

Lander Nominated for Science Advisor

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

What's Popular?

In Regulatory News & FDA Approvals

  1. Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

  2. MiRxes Receives CE Mark, Singapore Regulatory Approval for Multiplex SARS-CoV-2, Flu Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.